Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
undruggable targets
Research
AACR: KRAS inhibitors pop in preclinical data debuts
Verastem Oncology, Quanta Therapeutics, Frontier Medicines and more showed off new preclinical data on drugs against the once-”undruggable” target.
Helen Floersh
Apr 11, 2024 4:30am
Lilly inks backloaded $660M Prism drug discovery pact
Nov 29, 2023 5:53am
Roche pays $50M to Monte Rosa in latest molecular glue deal
Oct 17, 2023 8:25am
Sanofi pays $125M, offers up to $1.2B biobucks for Recludix deal
Jul 20, 2023 8:00am
Ginkgo, Boehringer Ingelheim team up on $406M discovery pact
May 8, 2023 7:00am
Daiichi taps Confo to hit once-undruggable target in $182M deal
Mar 30, 2023 5:00am